title: Atrial fibrillation in heart failure.
abstract: Heart failure (HF) and atrial fibrillation (AF) are highly prevalent debilitating conditions that often coexist and are frequently encountered in clinical practice. The presence of chronic AF is a marker of worse prognosis in patients with HF, and the onset of new AF in those with chronic HF is associated with increased morbidity and mortality. Advances in the development of novel drugs, nonpharmacologic modalities, and therapeutic strategies, as well the increased understanding of the pathobiology of HF and AF, are key to mitigating the tremendous public health burden that is associated with these conditions.
authors.affiliation: Division of Cardiology, Department of Medicine, University of California-San Francisco (Fresno-MEP), Fresno, CA 93701, USA.
authors.forename: Joel A
authors.initials: JA
authors.lastname: Lardizabal
authors.forename: Prakash C
authors.initials: PC
authors.lastname: Deedwania
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy; D006339:Heart Rate; D006801:Humans; D011379:Prognosis
chemical_list: D000889:Anti-Arrhythmia Agents